merged_ftc-pharmacy-benefit-managers-drug-prices.txt
<other>Looking at question 1 about the primary reason the FTC decided to bring a lawsuit against pharmacy benefit managers. The text states "The F.T.C. has so far stopped short of bringing a lawsuit or other enforcement action against a benefit manager." So they haven't brought a lawsuit.</other>

<question_number>1</question_number>
<answer>N/A</answer>

<other>Question 2 asks about when CVS Health acquired Caremark. The text mentions "CVS Health's Caremark" as one of the three largest benefit managers, but doesn't specify when CVS acquired Caremark.</other>

<question_number>2</question_number>
<answer>N/A</answer>

<other>Question 3 asks how much the FTC estimated patients overpaid for generic drugs. The text mentions $1.6 billion in revenue for the biggest three conglomerates from examining two generic cancer drugs, but this is about revenue, not about patient overpayment estimates.</other>

<question_number>3</question_number>
<answer>N/A</answer>